Showing results (601-610 of 1,089) with videos related to
Sort By:
Pageof 109
Journal of Geriatric Cardiology : JGC|August 8, 2018
Sphingosine 1 phosphate receptor-1 (S1PR1) signaling protects cardiac function by inhibiting cardiomyocyte autophagyYong-Zeng Chen, Fan Wang, Hai-Jun Wang, et al.Journal of Geriatric Cardiology : JGC|August 8, 2018
Optimal timing of staged percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with multivessel diseaseXue-Dong Zhao, Guan-Qi Zhao, Xiao Wang, et al.Journal of Geriatric Cardiology : JGC|October 18, 2021
Prospective evaluation of health status, quality of life and clinical outcomes following implantable defibrillator generator exchangeFaisal M Merchant, John Larson, Leon Darghosian, et al.Journal of Geriatric Cardiology : JGC|October 18, 2021
Beta-blockers and 1-year clinical outcomes in hospitalized heart failure patients with atrial fibrillationFu-Wei Xing, Li-Hua Zhang, Hai-Bo Zhang, et al.Journal of Geriatric Cardiology : JGC|October 18, 2021
Cardiac hybrid imaging: novel tracers for novel targetsAndrea Ponsiglione, Raffaele Ascione, Carmela Nappi, et al.Journal of Geriatric Cardiology : JGC|February 9, 2022
A different cardiac resynchronization therapy technique might be needed in some patients with nonspecific intraventricular conduction disturbance patternGábor Katona, Zsuzsanna Szelényi, Gábor Szénási, et al.Journal of Geriatric Cardiology : JGC|February 9, 2022
MiR-21-5p-expressing bone marrow mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury by regulating the circRNA_0031672/miR-21-5p/programmed cell death protein 4 pathwayJing Zhang, Chang-Jun Luo, Xiao-Qi Xiong, et al.Journal of Geriatric Cardiology : JGC|March 2, 2022
Atrial fibrillation in older adults with cancerManish Kumar, Nerea Lopetegui-Lia, Christina Al Malouf, et al.Journal of Geriatric Cardiology : JGC|September 2, 2025
Development of cardiovascular clinical research data warehouse and real-world researchDan-Dan Li, Ya-Ni Yu, Zhi-Jun Sun, et al.Journal of Geriatric Cardiology : JGC|September 2, 2025
Study design and rationale of the TXL-CAP trial: a randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaquesMei Ni, Yun Ti, Yan Qi, et al.Pageof 109